The future of fertility.
Juniper Genomics is shaping a better future for aspiring parents by enabling a faster, more successful IVF journey.
A new standard of care in PGT.
Juniper is the world’s first clinical embryo test that uses both whole genome trios and transcriptome sequencing.
Our test replaces all existing preimplantation genetic tests, giving patients and doctors all of the data they would get from PGT-A, PGT-M, and more. Our technology finds embryo errors that account for over 85% of IVF failures and pregnancy losses. We give families and clinicians the most complete, clinically-relevant insights into embryo viability so they can choose the embryos most likely to succeed.
01Collect the most input data, including DNA, RNA, and parental information
02Process and analyze this data to generate a rich dataset focused on IVF success
03Integrate this knowledge into a sophisticated algorithm and apply it to your embryo dataset
04Bring the data to life — choose a viable embryo on the first transfer for a shorter, more successful IVF journey
Boosting IVF
Current euploid embryo testing is only 55% successful because it only uses a fraction of the data available from the embryo. Even embryos that test “normal” fail almost 50% of the time. It’s time to do better.
Backed by Experts
Our team is committed to advancing the future of IVF. We are supported by some of the brightest minds from the world’s most renowned institutions and respected funding agencies.
Responsible & Ethical
We empower fertility decisions with validated, scientific information that has a true impact on fertility success. We are committed to making that technology accessible to as many people as possible.
Testimonials
When you do good things, good people talk.
